BioWorld MedTech

Aug. 14, 2014

First U.S. commercial Neuraceq scan for beta-amyloid plaque imaging

Piramal Imaging (Berlin) reported that WVU Healthcare (Morgantown, West Virginia) is the first U.S. center to perform commercial scans using the company's Neuraceq, which just became available for commercial use on Aug. 1. Read More

Asia in the Spotlight: High disease rate burden spurs Indian researchers in race to develop TB tests

Inside the Beltway: CMS considers HIV screening for all Medicare beneficiaries

Report from Europe: German law requires manufacturers provide implant card for patients

Financings: Castle raises $11.8M to expand availability of its cancer tests

Agreement/contracts: Alignment Healthcare to help out the Tar Heel State

Hit Bits: ZixCorp to provide UCHealth e-mail services across its healthcare system

Daily M&A: St. Jude Medical completes $200 million NeuroTherm buy

Patent Watch: Imris gets three Japanese patents for iMRI solution

World in Review: Study strongly supports value of screening for atherosclerosis

Product briefs

People in Places

MDD's Orthopedics Extra

Today's news in brief

BioWorld

BioWorld briefs for May 20, 2026.

News in brief

BioWorld Asia

BioWorld Asia briefs for May 19, 2026

WHO declares Ebola outbreak a public health emergency of international concern

BioWorld

The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...

Acid alpha-glucosidase molecular structure isolated on black

‘Detargeted’ targeted gene therapy improves activity in Pompe

BioWorld

A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...

Nxera Pharma prepares and tests new GPR17 antagonists

BioWorld Science

Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...